Dr. Falk PharmaFalk Foundation
  • About us
    About us
    • Now into the future
    • Innovation drives everything
    • Why we are
    • Partnering
    • Corporate Sustainability
    • Following the footsteps of our founder
    • Global presence
  • Events
    Events
    • Falk Forums
    • Falk Futures
    • Symposia
  • Falk Foundation Awards
    Falk Foundation Awards
    • Falk Foundation / Guts UK Awards
    • Falk Foundation Awards Ireland
    • Falk Foundation / BASL Awards
  • Product Overview
    Product Overview
    • Budenofalk®
    • Jorveza®
    • Salofalk®
    • Ursofalk®
  • Healthcare Professionals
    Healthcare Professionals
    • Eosinophilic Oesophagitis (EoE)
    • Inflammatory Bowel Diseases
    • Liver Diseases
    • Falk News
    • Our Apps
    • FalkPlus
    • Resources
  • Patient Support
    Patient Support
    • Eosinophilic Oesophagitis (EoE)
    • Inflammatory Bowel Diseases
    • Liver Diseases
    • Patient Apps
  • Falk+
Search
Please choose your country
  • Global (English)
  • Australia
  • België (Vlaams)
  • Belgique (Français)
  • Deutschland
  • España
  • France
  • Ireland
  • Italia
  • Luxembourg (Français)
  • Nederland
  • Österreich
  • Portugal
  • Россия
  • Schweiz (Deutsch)
  • Suisse (Français)
  • United Kingdom
more info

Contact:
Phone:+44 (0)1628 536600 Email: office@drfalkpharma.co.uk

  • Contact
  • Newsroom
  • Our Partnerships
  • Falk Foundation
  • Reporting misconduct
  • Declaration
  • Reporting Adverse Events
  • Basket
  • My Account
  • Follow us on X
  • Follow us on Linkedin
Login
  • About us
    • Now into the future
    • Innovation drives everything
    • Why we are
    • Partnering
    • Corporate Sustainability
    • Following the footsteps of our founder
    • Global presence
  • Events
    • Falk Forums
    • Falk Futures
    • Symposia
  • Falk Foundation Awards
    • Falk Foundation / Guts UK Awards
    • Falk Foundation Awards Ireland
    • Falk Foundation / BASL Awards
  • Product Overview
    • Budenofalk®
    • Jorveza®
    • Salofalk®
    • Ursofalk®
  • Healthcare Professionals
    • Eosinophilic Oesophagitis (EoE)
    • Inflammatory Bowel Diseases
    • Liver Diseases
    • Falk News
    • Our Apps
    • FalkPlus
    • Resources
  • Patient Support
    • Eosinophilic Oesophagitis (EoE)
    • Inflammatory Bowel Diseases
    • Liver Diseases
    • Patient Apps
  • Falk+
  • Contact
  • Newsroom
  • Our Partnerships
  • Falk Foundation
  • Reporting misconduct
  • Declaration
  • Reporting Adverse Events
  • Basket
  • My Account
  • Follow us on X
  • Follow us on Linkedin
Contact:
Phone:
+44 (0)1628 536600
Email:
office[at]drfalkpharma.co.uk
  • Homepage
  • Search

Search results

185 results

  • Resources
    Informed Patient Corticosteroid therapy in inflammatory bowel disease
  • Jorveza®
    Products Homepage Product Overview Jorveza ® Jorveza ® Jorveza ® is an orodispersible tablet containing the topically acting corticosteroid budesonide. The formulation has been specifically developed…
  • Pricing and Market Access Sustainability Policy
    Pricing and Market Access Homepage About us Corporate Sustainability Pricing and Market Access Sustainability Policy Dr. Falk Pharma Pricing and Market Access Sustainability Policy Dr. Falk Pharma is…
  • NEWSROOM
    Falk Foundation Awards
    Best IBD & EOE Posters 2026 Application closes 3rd November 2025
  • NEWSROOM
    UEG Week 2025
    We look forward to seeing you at booth 4.27 in Berlin from October 4 - 7, 2025!
  • NEWSROOM
    Raising Awareness for PBC
    September is PBC Awareness Month
  • 2025 Award Winners
    The Winners Dr. Falk / BASL Homepage Dr. Falk Awards Dr. Falk / BASL Awards 2025 Award Winners 2025 Award Winners Innovation Award Dr William Rowley Whiston Hospital Liverpool & The Royal Liverpool…
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • »
Falk Foundation

Discover the range of continuing education opportunities for physicians and pharmacists provided by the Falk Foundation e.V.

Dr. Falk Pharma UK

Dr. Falk Pharma is the expert in digestive and metabolic medicine. As a research-based family business with global presence, we focus on the development and distribution of innovative medicines that improve patients’ health and well-being.

 UI—2400183 April 2025

  • About us
  • Events
  • Contact
  • Reporting misconduct
  • Basket
  • Products
  • Patients
  • Social Media Community Guidelines
  • Reporting Adverse Events
© 2026 Dr. Falk Pharma UK Ltd | Company Registration Number: 2307698
  • Privacy Policy
  • Terms & Conditions
Notice

This website is an international information resource intended for healthcare professionals outside the United States (US) and United Kingdom (UK).

I am a health care professional outside the US and UK.

Accept
UK Login
Notice
I confirm I am a UK or Irish resident and have been prescribed either Budenofalk®, Jorveza®, Salofalk® or Ursofalk®
Accept

You are now leaving uk.drfalkpharma.com for an external website.

Dr Falk Pharma UK accepts no responsibility for the content of other websites.